Answers are grounded in this paper and cite their sources.
Pilot randomized trial evaluates virtual reality for pain reduction in sickle cell disease, indicating potential self-management benefits.
Background/Objectives: Non-pharmacological approaches are urgently required for managing chronic pain in sickle cell disease (SCD). This multiple-method, exploratory pilot randomized trial was conducted to evaluate preliminary benefits of an in-home virtual reality (VR) intervention (EaseVRx), compared to content-matched audio attention control, for chronic pain reduction and changes to chronic pain-related outcomes in adults with SCD. Methods: Participants were randomized to VR (19) or audio (25), with 2–16 min daily modules for eight weeks, a daily pain diary survey, VR surveys, assessments of chronic pain grade and chronic pain correlates every 4 weeks for 3 months, and a qualitative interview. Analyses were conducted using quantitative and qualitative methods. Clinical Trial Registration: ClinicalTrials.gov, NCT04906707, 27 May 2021. Results: Average intervention use was 19.1 and 12.1 min per day in VR and audio, respectively. Preliminary benefits of VR included decreased pain (p = 0.002), improved pain coping (pain catastrophizing [p = 0.005] and chronic pain acceptance [p = 0.002]), and improved sleep (p = 0.009). Additionally, symptoms associated with cybersickness were significantly lower (p = 0.012) after VR use than before VR use. Among interviewees, the interventions were acceptable and helpful in managing pain, although there were some barriers and challenges to use. Conclusions: Study findings suggest that in-home VR may be a self-management resource for adults with SCD and warrants additional research.
No takes yet. Share an insight, caveat, or question.
Matthie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: